Brain-Enriched Guanylate Kinase-Associated (BEGAIN) (Middle Region) Peptid
BEGAIN
Reaktivität: Human
Wirt: Synthetic
BP, WB
Kurzübersicht für Brain-Enriched Guanylate Kinase-Associated (BEGAIN) (Middle Region) Peptid (ABIN973801)
Target
BEGAIN
(Brain-Enriched Guanylate Kinase-Associated (BEGAIN))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- AEAAAFPAGF QHEAFPSYAG SLPTSSSYSS FSATSEEKEH AQASTLTASQ
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BEGAIN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BEGAIN (Brain-Enriched Guanylate Kinase-Associated (BEGAIN))
-
Hintergrund
-
BEGAIN may sustain the structure of the postsynaptic density (PSD).
Alias Symbols: KIAA1446
Protein Interaction Partner: ABLIM1,BAHD1,BEGAIN,C16orf48,C17orf28,CATSPER1,DEF6,DLG1,DLG4,DTNB,FAM107A,GFI1B,HGS,KIAA0408,RBL1,RIBC2,TRIM27,USP2,ZFP64,ZNF250,ZNF417,ABLIM1,BAHD1,BEGAIN,C16orf48,C17orf28,CATSPER1,Cep170,DEF6,DTNB,FAM107A,HGS,Haus1,Haus4,KIAA0408,Ndc80,RBL1,RIBC2,TRIM27,USP2,ZFP64,ZNF250,ZNF417
Protein Size: 593 -
Molekulargewicht
- 65 kDa
-
Gen-ID
- 57596
-
NCBI Accession
- NM_020836, NP_065887
-
UniProt
- Q9BUH8
Target
-
Sie sind hier:
